| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MED7 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | NOL9 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ARHGEF26 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | WBP2NL | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PHACTR3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CTC-360G5.8 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | DEFA5 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | TAPBP | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PDE6H | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | YBX1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
